Neurogene Stock Overlap Studies Parabolic SAR Extended

NGNE Stock   22.62  0.12  0.53%   
Neurogene overlap studies tool provides the execution environment for running the Parabolic SAR Extended study and other technical functions against Neurogene. Neurogene value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Parabolic SAR Extended study function is designed to identify and follow existing trends. Neurogene overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify the following input to run this model: Start Value, Offset on Reverse, AF Init Long, AF Long, AF Max Long, AF Init Short, AF Short, and AF Max Short.

Study
Start Value
Offset on Reverse
AF Init Long
AF Long
AF Max Long
AF Init Short
AF Short
AF Max Short
Execute Study
The output start index for this execution was one with a total number of output elements of sixty. The Extended Parabolic SAR indicator is used to determine the direction of Neurogene's momentum and the point in time when it has higher than normal probability of directional change. It has more input parameters than standard Parabolic SAR indicator.

Neurogene Technical Analysis Modules

Most technical analysis of Neurogene help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neurogene from various momentum indicators to cycle indicators. When you analyze Neurogene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Neurogene Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neurogene. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neurogene based on widely used predictive technical indicators. In general, we focus on analyzing Neurogene Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neurogene's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Neurogene's intrinsic value. In addition to deriving basic predictive indicators for Neurogene, we also check how macroeconomic factors affect Neurogene price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2023 2024 (projected)
Payables Turnover5.111.260.86
Days Of Inventory On Hand123.11141.58236.37
Hype
Prediction
LowEstimatedHigh
10.6522.2833.91
Details
Intrinsic
Valuation
LowRealHigh
14.6126.2437.87
Details
Naive
Forecast
LowNextHigh
8.2119.8431.47
Details
7 Analysts
Consensus
LowTargetHigh
34.5838.0042.18
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
Investor Favorites Idea
Investor Favorites
Invested over 200 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Impulse Idea
Impulse
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Trump Equities Idea
Trump Equities
Invested few shares
When determining whether Neurogene is a strong investment it is important to analyze Neurogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neurogene's future performance. For an informed investment choice regarding Neurogene Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurogene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Neurogene Stock refer to our How to Trade Neurogene Stock guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurogene. If investors know Neurogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.66)
Revenue Per Share
0.106
Return On Assets
(0.32)
Return On Equity
(0.41)
The market value of Neurogene is measured differently than its book value, which is the value of Neurogene that is recorded on the company's balance sheet. Investors also form their own opinion of Neurogene's value that differs from its market value or its book value, called intrinsic value, which is Neurogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurogene's market value can be influenced by many factors that don't directly affect Neurogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.